Frost & Sullivan: Pharmaceuticals, Biotechnology & Drug Discovery Technologies
To achieve continued double digit growth and mitigate risks in R&D and manufacturing, pharma companies must gather actionable intelligence that will enable them to move rapidly from quantity-based, fee-for-service model to outcomes based contracts and adopt new digital platforms to deliver targeted therapeutics and improve profitability in a transformed healthcare market.
Know anyone building innovative solutions that belong in this 'Pharmaceuticals, Biotechnology & Drug Discovery Technologies'?
The assurance cookie is found and is being filtered in Google Analytics.
These cookies are used to collect information about how you interact
with our website and allow us to remember you. We use this
information in order to improve and customize your browsing
experience, and for analytics and metrics about our visitors both on
this website and other media. To find out more about the cookies we
use, see our